Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET
Category: Sexually Transmitted Diseases
A recent study published in JAMA revealed that the sustained virological response (SVR) that comes from interferon-based treatment in patients who have hepatitis C may increase their chances of survival. SVR occurs when a patient has undetectable levels of the virus in the bloodstream.
During the study, Adriaan J. van der Meer, M.D., of Erasmus MC University Medical Center in the Netherlands, along with his colleagues, analyzed 530 patients at five different hospitals in Europe and Canada who had contracted hepatitis C and undergone interferon-based treatments between 1990 and 2003. They then had follow-up analyses between January 2010 and October 2011.
Out of the 192 patients who had SVR, only 13 died, while 100 of the patients without SVR died. Other factors that contributed to patient fatalities included age, HCV genotype 3 infection, diabetes and alcohol abuse. Of all the patients who did not achieve SVR who died, 70 of the deaths were attributed to liver-related ailments, 15 of the deaths were non-liver related and the other 15 percent of the deaths were from unknown causes.
The researchers also revealed that patients who did not have SVR were more likely to need a transplant and had higher rates of other complications like liver failure and hepatocellular carcinoma, which is a malignant tumor.
"Our study with a long follow-up duration demonstrated a lower risk for all-cause mortality in patients with chronic HCV infection and advanced hepatic fibrosis who achieved SVR," noted the study authors. "In addition, we were able to further establish and quantify the risk reduction of HCC, liver failure and liver-related mortality or liver transplantation in patients with SVR."
Hepatitis C facts and statistics
According to Oxford Journals, approximately 170 million people throughout the world have contracted hepatitis C, and it is the leading cause of liver disease fatalities in the United States.
Some symptoms of hepatitis C include abdominal pain, clay-colored stools, dark urine, fatigue, fever, itching, jaundice, nausea and vomiting. A blood test for the disease's antibody is usually issued to diagnose the condition, reports the National Institutes of Health. A subsequent test may be conducted to test for the viral load. Patients may also have genetic testing conducted to find out which genotype of the virus they have. A majority of the people who contract the virus have a genotype 1 infection, which is the most difficult to treat, while genotype 2 and genotype 3 respond better to treatment.
Related Articles from Private MD:
News Categories:Advanced Lipid Treatment I Allergy Testing Anemia and RBC disorders Autoimmune Diseases Bariatric Lab Testing Blood and Blood Diseases Breast Cancer Detection and Tumor Markers Celiac Disease Testing Chlamydia Coagulation and blood clotting disorders Colon Diabetes DNA, Paternity and Genetic testing Drug Screening Environmental Toxin Testing Female Specific Tests Gastrointestinal Diseases General Health General Wellness Heart Health and Cholesterol Herpes HIV HIV monitoring/Treatment/Testing/Post Diagnos Hormones and Metabolism Infectious Diseases Infertility Testing-Male Infertitlity Hormone Testing Kidney Diseases Leukemia and WBC disorders Liver Liver Diseases Lyme Disease Male Specific Tests Menopause/Peri-Menopausal Diagnosis Musculoskeletal Diseases Organ Specific Testing Ovarian Prostate Sexually Transmitted Diseases Thyroid Diseases Transgender Hormone Testing-female to male Transgender Hormone Testing-Male to Female Vitamin D Deficiency-Diagnosis and Treatment
Visit the Health News Archive: Click Here
Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our professionals are ready to assist you.Back to top